ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B8FHGS14
Stock Name / FundiShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMINV(GBX) LSE
ETF TickerIQQ0(EUR) F
ETF TickerMINV.LS(GBX) CXE
ETF TickerMVOL.LS(USD) CXE
ETF TickerMVOL.MI(EUR) CXE
ETF TickerMVOLz(CHF) CXE
ETF TickerMVOL(EUR) ETF Plus
ETF TickerMINV.L(GBP) LSE

Holdings detail for BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright
HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout
In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.
Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET
(RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.
Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc) BMRN holdings

DateNumber of BMRN Shares HeldBase Market Value of BMRN SharesLocal Market Value of BMRN SharesChange in BMRN Shares HeldChange in BMRN Base ValueCurrent Price per BMRN Share HeldPrevious Price per BMRN Share Held
2025-11-21 (Friday)52,270USD 2,858,646BMRN holding increased by 115516USD 2,858,6460USD 115,516 USD 54.69 USD 52.48
2025-11-20 (Thursday)52,270USD 2,743,130BMRN holding decreased by -4181USD 2,743,1300USD -4,181 USD 52.48 USD 52.56
2025-11-19 (Wednesday)52,270USD 2,747,311BMRN holding decreased by -83632USD 2,747,3110USD -83,632 USD 52.56 USD 54.16
2025-11-18 (Tuesday)52,270USD 2,830,943BMRN holding decreased by -15681USD 2,830,9430USD -15,681 USD 54.16 USD 54.46
2025-11-17 (Monday)52,270BMRN holding increased by 251USD 2,846,624BMRN holding decreased by -376USD 2,846,624251USD -376 USD 54.46 USD 54.73
2025-11-14 (Friday)52,019BMRN holding decreased by -502USD 2,847,000BMRN holding decreased by -689USD 2,847,000-502USD -689 USD 54.73 USD 54.22
2025-11-13 (Thursday)52,521USD 2,847,689BMRN holding decreased by -57773USD 2,847,6890USD -57,773 USD 54.22 USD 55.32
2025-11-12 (Wednesday)52,521USD 2,905,462BMRN holding increased by 20483USD 2,905,4620USD 20,483 USD 55.32 USD 54.93
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00B8FHGS14

Show aggregate share trades of BMRN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-17BUY25155.24054.000 54.124USD 13,585 61.16
2025-11-14SELL-50255.29553.670 53.832USD -27,024 61.19 Profit of 3,693 on sale
2025-11-04SELL-53052.76051.800 51.896USD -27,505 61.51 Profit of 5,096 on sale
2025-10-31BUY25153.62051.020 51.280USD 12,871 61.60
2025-10-28SELL-50453.49056.800 56.469USD -28,460 61.74 Profit of 2,656 on sale
2025-10-21SELL-50053.81053.980 53.963USD -26,981 61.95 Profit of 3,994 on sale
2025-10-14SELL-25152.47052.810 52.776USD -13,247 62.20 Profit of 2,364 on sale
2025-10-02SELL-99655.57055.990 55.948USD -55,724 62.27 Profit of 6,296 on sale
2025-09-25SELL-25052.62054.500 54.312USD -13,578 62.51 Profit of 2,049 on sale
2025-09-24SELL-1,10053.77053.870 53.860USD -59,246 62.56 Profit of 9,567 on sale
2025-09-16BUY22753.94054.420 54.372USD 12,342 62.70
2025-07-23SELL-1,21759.67060.430 60.354USD -73,451 63.05 Profit of 3,279 on sale
2025-07-22SELL-1,58459.20059.220 59.218USD -93,801 63.07 Profit of 6,106 on sale
2025-07-21SELL-79256.56057.550 57.451USD -45,501 63.11 Profit of 4,486 on sale
2025-07-15SELL-1,57656.62058.670 58.465USD -92,141 63.26 Profit of 7,554 on sale
2025-07-11SELL-78858.10058.500 58.460USD -46,066 63.33 Profit of 3,834 on sale
2025-07-02BUY39457.17057.610 57.566USD 22,681 63.59
2025-06-30SELL-1,19454.97055.960 55.861USD -66,698 63.65 Profit of 9,296 on sale
2025-06-27SELL-1,32655.17055.200 55.197USD -73,191 63.71 Profit of 11,284 on sale
2025-06-26BUY39654.10054.550 54.505USD 21,584 63.78
2025-06-25SELL-39854.14054.610 54.563USD -21,716 63.85 Profit of 3,694 on sale
2025-06-16SELL-4,07256.24056.510 56.483USD -229,999 64.16 Profit of 31,279 on sale
2025-06-13SELL-39756.22057.360 57.246USD -22,727 64.22 Profit of 2,770 on sale
2025-06-12SELL-79457.28057.650 57.613USD -45,745 64.28 Profit of 5,291 on sale
2025-06-11SELL-1,98557.16057.990 57.907USD -114,945 64.33 Profit of 12,752 on sale
2025-06-09SELL-39756.88057.460 57.402USD -22,789 64.44 Profit of 2,795 on sale
2025-05-30SELL-39358.07058.480 58.439USD -22,967 64.82 Profit of 2,508 on sale
2025-05-28SELL-39158.09059.120 59.017USD -23,076 64.93 Profit of 2,312 on sale
2025-05-21SELL-39158.48059.510 59.407USD -23,228 65.23 Profit of 2,277 on sale
2025-05-14SELL-5,12258.70060.030 59.897USD -306,792 65.51 Profit of 28,729 on sale
2025-05-09BUY2,01558.86060.660 60.480USD 121,867 65.66
2025-05-07SELL-1,55659.32060.160 60.076USD -93,478 65.77 Profit of 8,866 on sale
2025-05-01BUY38962.71063.620 63.529USD 24,713 65.94
2025-04-29SELL-4,24663.28064.080 64.000USD -271,744 65.99 Profit of 8,433 on sale
2025-04-28BUY5,20162.98063.870 63.781USD 331,725 66.02
2025-04-25BUY37463.30063.440 63.426USD 23,721 66.04
2025-04-23BUY1,24561.94063.390 63.245USD 78,740 66.12
2025-04-22BUY3,38461.50061.530 61.527USD 208,207 66.17
2025-04-15SELL-1,12860.02060.930 60.839USD -68,626 66.47 Profit of 6,354 on sale
2025-04-14BUY2,01459.67059.990 59.958USD 120,755 66.55
2025-04-11BUY1,90056.82057.000 56.982USD 108,266 66.66
2025-04-09SELL-1,12259.43059.880 59.835USD -67,135 66.86 Profit of 7,881 on sale
2025-04-08SELL-1,49655.89061.070 60.552USD -90,586 66.99 Profit of 9,626 on sale
2025-04-07SELL-37459.16060.610 60.465USD -22,614 67.08 Profit of 2,473 on sale
2025-04-04BUY37660.26066.490 65.867USD 24,766 67.16
2025-04-01BUY1,50067.94070.630 70.361USD 105,541 67.14
2025-03-27SELL-75472.83073.180 73.145USD -55,151 66.96 Loss of -4,660 on sale
2025-03-21SELL-37671.24072.060 71.978USD -27,064 66.72 Loss of -1,977 on sale
2025-03-14BUY1,13469.44070.410 70.313USD 79,735 66.41
2025-03-13BUY37870.60071.930 71.797USD 27,139 66.35
2025-03-12BUY75670.54070.820 70.792USD 53,519 66.29
2025-03-11BUY75670.49072.350 72.164USD 54,556 66.22
2025-03-10SELL-37772.03072.990 72.894USD -27,481 66.13 Loss of -2,548 on sale
2025-03-07BUY6,42672.23073.510 73.382USD 471,553 66.04
2025-03-05BUY1,88071.19071.470 71.442USD 134,311 65.96
2025-03-04BUY75270.51071.580 71.473USD 53,748 65.89
2025-03-03BUY1,50471.02071.700 71.632USD 107,735 65.81
2025-02-27BUY37669.12070.070 69.975USD 26,311 65.66
2025-02-26BUY2,99268.81071.300 71.051USD 212,585 65.61
2025-02-25BUY74671.17071.580 71.539USD 53,368 65.51
2025-02-20BUY1,12268.73070.500 70.323USD 78,902 65.34
2025-02-05BUY37164.19064.530 64.496USD 23,928 65.54
2025-02-04BUY37162.87063.530 63.464USD 23,545 65.60
2025-01-31SELL-37263.36064.330 64.233USD -23,895 65.73 Profit of 558 on sale
2025-01-30BUY37263.88064.230 64.195USD 23,881 65.78
2025-01-29SELL-37163.46064.050 63.991USD -23,741 65.84 Profit of 686 on sale
2025-01-28BUY74463.25063.480 63.457USD 47,212 65.91
2025-01-27SELL-37261.80063.150 63.015USD -23,442 66.02 Profit of 1,117 on sale
2024-12-10SELL-37966.43067.070 67.006USD -25,395 66.37 Loss of -240 on sale
2024-12-03SELL-75863.19065.130 64.936USD -49,221 66.46 Profit of 1,155 on sale
2024-11-29SELL-37966.03066.170 66.156USD -25,073 66.53 Profit of 142 on sale
2024-11-22SELL-1,13764.26064.460 64.440USD -73,268 66.89 Profit of 2,788 on sale
2024-11-05SELL-3,02466.04066.230 66.211USD -200,222 68.74 Profit of 7,645 on sale
2024-10-29BUY37769.91070.560 70.495USD 26,577 70.17
2024-10-24BUY37770.39070.980 70.921USD 26,737 70.26
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19410,0268,500779,51352.6%
2025-09-18309,9349,272546,27156.7%
2025-09-17792,001761,198,91966.1%
2025-09-16481,50501,174,96941.0%
2025-09-15537,10968901,19259.6%
2025-09-12559,51941804,63869.5%
2025-09-11479,992858740,03264.9%
2025-09-10670,394301865,41977.5%
2025-09-09347,7870583,41259.6%
2025-09-08440,4270726,53560.6%
2025-09-05291,8700466,53662.6%
2025-09-04516,7790829,87862.3%
2025-09-03280,8020490,76857.2%
2025-09-02312,7570686,20245.6%
2025-08-29214,12613370,04357.9%
2025-08-28251,9167439,79557.3%
2025-08-27370,3496578,90564.0%
2025-08-26289,675233549,90452.7%
2025-08-25355,827100585,45360.8%
2025-08-22357,18416556,52864.2%
2025-08-21352,5011,525524,29367.2%
2025-08-20339,77774602,58956.4%
2025-08-19220,4370499,04144.2%
2025-08-18330,939435644,69651.3%
2025-08-15498,8220931,91353.5%
2025-08-14241,4360529,66845.6%
2025-08-13719,9923501,132,11263.6%
2025-08-12217,2424606,98935.8%
2025-08-11336,9850722,60446.6%
2025-08-08574,538391,320,70843.5%
2025-08-07387,50431837,24046.3%
2025-08-06571,71843896,31463.8%
2025-08-051,685,68712,5033,542,20047.6%
2025-08-041,579,75703,686,25742.9%
2025-08-01716,52602,200,77732.6%
2025-07-31549,45938925,08459.4%
2025-07-30718,573101,234,75558.2%
2025-07-29226,72575481,37547.1%
2025-07-28243,6265412,92959.0%
2025-07-25247,29586445,58755.5%
2025-07-24380,699137586,87264.9%
2025-07-23251,7130450,21955.9%
2025-07-22387,886114638,28360.8%
2025-07-21228,3756,803346,20866.0%
2025-07-18292,003100575,02850.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.